Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Protocol for Sub-Study of the ASCOT Trial
  • Published:

Protocol for Sub-study of the ASCOT Trial

Effects of atorvastatin (and blood pressure lowering comparing amlodipide-based therapy with beta-blocker-based therapy) on serum variables of cholesterol synthesis and absorption, thrombogenicity and on low-density lipoprotein oxidation in vivo

Journal of Human Hypertension volume 15, pages S27–S29 (2001)Cite this article

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Superko HR Beyond LDL cholesterol reduction Circulation 1996 94 2351–2354

    Article  CAS  Google Scholar 

  2. Kreisberg RA Cholesterol-lowering and coronary atherosclerosis: good news and bad news Am J Med 1996 101 455–458

    Article  CAS  Google Scholar 

  3. Bakker-Arkema RG et alEfficacy and safety of a new HMG-CoA reductase inhibitor, atrovastatin, inpatients with hypertriglyceridemia JAMA 1996 275 128–133

    Article  CAS  Google Scholar 

  4. Stampfer MJ et alA prospective study of triglycerides, LDL particle diameter, and risk of myocardial infarction JAMA 1996 276 882–888

    Article  CAS  Google Scholar 

  5. Coresh J, Kwiterovich PO Jr Small, dense low-density lipoprotein particles and coronary heart disease risk JAMA 1996 276 914–915

    Article  CAS  Google Scholar 

  6. Miettinen TA, Strandberg TE, Vanhanen H, Gylling H, for the 4S Group Noncholesterol serum sterols in the Scandinavian Simvastatin Survival Study. XII International Symposium on Drugs Affecting Lipid Metabolism November 7–10 1995; Houston Texas. Abstracts p 34

    Google Scholar 

  7. Strandberg TE, Salomaa V, Vanhanen H, Miettinen TA Associations of fasting blood glucose with cholesterol absorption and synthesis in nondiabetic middle-aged men Diabetes 1996 45 755–761

    Article  CAS  Google Scholar 

  8. Manninen V et alJoint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study Circulation 1992 85 37–45

    Article  CAS  Google Scholar 

  9. Anonymous And now all this (Editorial) Lancet 1997 349 1

    Google Scholar 

  10. Haq U et alLipid-lowering for prevention of coronary heart disease: what policy now? Clin Sci 1996 91 399–413

    Article  Google Scholar 

  11. Berliner JA, Heinecke JW The role of oxidized lipoproteins in atherosclerosis Free Rad Biol Med 1996 20 707–727

    Article  CAS  Google Scholar 

  12. Esterbauer H, Gebicky J, Puhl H, Jurgens G The role of lipid peroxidation and antioxidants in oxidative modification of LDL Free Biol Med 1992 13 341–390

    Article  CAS  Google Scholar 

  13. Giroux LM, Davignon J, Naruszewich M Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophages Biochim Biophys Acta 1993 1165 335–338

    Article  CAS  Google Scholar 

  14. Ahotupa M, Ruutu M, Mäntylä E Simple methods for quantifying oxidaton products and antioxidant potential of low density lipoproteins Clin Biochem 1996 29 139–144

    Article  CAS  Google Scholar 

  15. Ahotupa M et alBaseline diene conjugation in LDL lipids as a direct measure of in vivo LDL oxidation 1997 Submitted for publication

  16. Vasankari T et alEffets of acute prolonged physical exercise on serum and LDL oxidation antioxidant defences Free Radical Biol Med 1997 22 509–513

    Article  CAS  Google Scholar 

  17. Kujala UM et alLow LDL oxidation in veteran endurace athletes Scand J Med Sci Sports 1996 6 303–308

    Article  CAS  Google Scholar 

  18. Vasankari T et al Effect of weight reduction on LDL oxidation. In: Väisänen S, Suomela-Markkanen T, Rankinen T (eds). International 14th Puijo Symposium “Physical Activity, Diet and Cardiovascular Diseases – A Fresh Look Beyond Old Facts”. Kuopion yliopiston julkaisuja D Lääketiede 101, Kuopio 1996

    Google Scholar 

  19. Peltola V, Vasankari T, Viikari J, Ahotupa M Lipid peroxidation in diabeticpatients: relations to hypertriglyceridemia, obesity and hyperglycemia. Abstract in the 16th IHD Congress. Helsinki 25–29 July 1997

  20. Kujala U et alFamilial aggregation of LDL oxidation Scand J Lab Invest (in press)

  21. Vasankari T et alIncreased serum and LDL antioxidant potential after antioxidant supplementation in endurance athletes Am J Clin Nutr 1997 65 1952–1056

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Cardiology, Helsinki University Hospital, Haartmaininkatu 4, Helsinki, 00290, Finland

    MS Nieminen, T Strandberg & H Vanhanen

  2. Department of Medicine, University of Turku, Kiinanmyllynkatu 10, Turku, 20520, Finland

    J Viikari & I Kantola

  3. Department of Physiology, University of Turku, Kiinanmyllynkatu 10, Turku, 20520, Finland

    M Ahotupa & T Vasankari

Authors
  1. MS Nieminen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J Viikari
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Ahotupa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T Vasankari
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. I Kantola
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T Strandberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H Vanhanen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nieminen, M., Viikari, J., Ahotupa, M. et al. Effects of atorvastatin (and blood pressure lowering comparing amlodipide-based therapy with beta-blocker-based therapy) on serum variables of cholesterol synthesis and absorption, thrombogenicity and on low-density lipoprotein oxidation in vivo. J Hum Hypertens 15 (Suppl 1), S27–S29 (2001). https://doi.org/10.1038/sj.jhh.1001083

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001083

Keywords

Search

Advanced search

Quick links